Close Menu

NEW YORK – Agilent Technologies reported after the close of the market on Tuesday that its fiscal first quarter revenues rose 6 percent year over year.

For the three months ended Jan. 31, the firm said revenues rose to $1.36 billion from $1.28 billion a year ago, beating analysts' average estimate of $1.35 billion. The company said core revenues grew 2 percent in Q1.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.